Concepedia

Author

Fulvia Troise

University of Naples Federico IIORCID

Also Known As

F Troise, F. Troise, Fulvia Troise, Troise, Fulvia

57

Publications

843

Citations

14

H-Index

34

Concepts

All Affiliations

University of Naples Federico IICeinge Biotecnologie Avanzate (Italy)Nouscom (Italy)University of TurinInserm
FT

About

Fulvia Troise is an author at University of Naples Federico II specializing in medicine, immunology, and immunotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

291

2

Cell Biology

3

3

132

3

Health Sciences

1

1

15

4

Allergy

1

1

48

5

Biochemistry

1

1

46

Fulvia Troise

×

18

Publications

801

Citations

14

H-Index

YearCitations

Optineurin Increases Cell Survival and Translocates to the Nucleus in a Rab8-dependent Manner upon an Apoptotic Stimulus

Nadia De Marco, Mario Buono, Fulvia Troise,

Journal of Biological Chemistry

2006

133

MAIT cell activation augments adenovirus vector vaccine immunogenicity

Nicholas M. Provine, Ali Amini, Lucy C. Garner,

Science

2021

129

Adenoviral vaccine targeting multiple neoantigens as strategy to eradicate large tumors combined with checkpoint blockade

Anna Morena D’Alise, Guido Leoni, Gabriella Cotugno,

Nature Communications

2019

98

A Genetic Vaccine Encoding Shared Cancer Neoantigens to Treat Tumors with Microsatellite Instability

Guido Leoni, Anna Morena D’Alise, Gabriella Cotugno,

Cancer Research

2020

77

Human anti-nucleolin recombinant immunoagent for cancer therapy

Dario Palmieri, Timothy Richmond, Claudia Piovan,

Proceedings of the National Academy of Sciences

2015

67

Differential binding of human immunoagents and Herceptin to the ErbB2 receptor

Fulvia Troise, Valeria Cafaro, Concetta Giancola,

FEBS Journal

2008

48

Multimerization and Retention of the Scavenger Receptor SR-B1 in the Plasma Membrane

Pedro Elias Marques, Steffen Nyegaard, Richard F. Collins,

Developmental Cell

2019

46

Intracellular route and mechanism of action of ERB‐hRNase, a human anti‐ErbB2 anticancer immunoagent

Claudia De Lorenzo, Chiara Di Malta, Fulvia Troise,

FEBS Letters

2007

34

Targeting a host-cell entry factor barricades antiviral-resistant HCV variants from on-therapy breakthrough in human-liver mice

Koen Vercauteren, Richard J. P. Brown, Ahmed Atef Mesalam,

Gut

2015

29

Targeted invalidation of SR-B1 in macrophages reduces macrophage apoptosis and accelerates atherosclerosis

Lauriane Galle-Treger, Martine Moreau, Raphaëlle Ballaire,

Cardiovascular Research

2019

27

Page 1